Related Experiment Video
Updated: Jun 11, 2026
07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
The immunogenicity of therapeutic proteins
1Department of Pharmaceutical Sciences and Department of Innovation Studies, Utrecht University, Rotterdam, Netherlands. h.schellekens@uu.nl
Discovery Medicine
|July 1, 2010
Summary
Therapeutic proteins often trigger immune responses, leading to antibodies that can cause severe issues. Recent advancements improve understanding and management of this protein immunogenicity in patients.
Area of Science:
- Biotechnology
- Immunology
- Pharmacology
Background:
- Therapeutic proteins are widely used in medicine.
- Antibody formation against therapeutic proteins (immunogenicity) is a common issue.
- The clinical consequences of immunogenicity are often severe but historically neglected.
Purpose of the Study:
- To highlight the significance of immunogenicity in therapeutic protein therapy.
- To review recent progress in understanding protein immunogenicity.
- To discuss strategies for managing immunogenicity.
Main Methods:
- Review of existing literature on therapeutic protein immunogenicity.
- Analysis of factors contributing to patient antibody response.
- Examination of current and emerging management approaches.
Main Results:
- Immunogenicity is a prevalent and consequential aspect of therapeutic protein use.
- Significant progress has been made in elucidating the mechanisms of immunogenicity.
- Effective strategies for managing immunogenicity are becoming available.
Conclusions:
- Addressing protein immunogenicity is crucial for patient safety and therapeutic efficacy.
- Further research and clinical attention are needed to mitigate the risks associated with immunogenicity.
- Improved understanding facilitates better patient outcomes in protein-based therapies.
Related Concept Videos
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:20Immunoprecipitation
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.